Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A comparative study of sensitizers and liposome composition in radiation- induced controlled drug release for cancer therapy

  • Loscertales, E.
  • Mateo, J.
  • España, Samuel
12 páginas, 6 figuras, 2 tablas., This study investigates drug-loaded liposomes designed for controlled release under ionizing radiation to refine cancer treatment precision. liposomes as carriers enable targeted chemotherapy delivery, reducing healthy tissue damage risk. liposomes containing poly- or mono-unsaturated fatty acids and various sensitizing agents were assessed for responsiveness to UV light and γ photon irradiation including rose bengal (RB), protoporphyrin iX (PPiX), verteporfin (VP), cercosporin (ceRc) and hypericin (hYP). carboxyfluorescein (cF) was used as a surrogate for drug release measurements. VP and PPiX induced rapid drug release and lipid peroxidation under UV light, while RB prompted quick drug release under UV light and a modest immediate release under γ irradiation, eventually reaching full release a few hours after irradiation, demonstrating dose-dependent effects. smaller liposomes displayed accelerated release, emphasizing size-dependent kinetics. In vitro analyses evaluated radiosensitizing effects of RB-loaded liposomes. clonogenic assays indicated that RB-filled liposomes had minimal direct radiobiological effects but increased indirect radiation damage, as shown by the curvature of the cell survival curve. Our study sheds light on factors influencing liposomal drug release under ionizing radiation, spotlighting RB as a promising radiosensitizer requiring further investigation for cancer therapy potential., This work was funded by Comunidad de Madrid under ASAP project (S2022/BMD-7434) and MCIN/AEI/10.13039/501100011033 under NANORADIOTHER Project (PID2021-127033OB-C22). S. España is supported by the Ministerio de Ciencia, Innovación y Universidades under Ayudas Ramón y Cajal RYC2018-024495-I. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN, and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of gold nanoparticle size and coating on radiosensitization and generation of reactive oxygen species in cancer therapy

  • Loscertales, E.
  • López-Méndez, R.
  • Mateo, J.
  • Fraile, L.M.
  • Udias, J.M.
  • Espinosa, A.
  • España, Samuel
11 páginas, 11 figuras, 3 tablas., Advance Article, Radiation therapy is a common cancer treatment but often damages surrounding healthy tissues, leading to unwanted side effects. Despite technological advancements aimed at improving targeting, minimizing exposure to normal cells remains a major challenge. High-Z nanoparticles, such as gold nanoparticles (AuNPs), are being explored as nano-radiosensitizers to enhance cancer treatment through physical, biological, and chemical mechanisms. This study focuses on evaluating the chemical and biological radiosensitizing effects of AuNPs exposed to ionizing radiation (0-50 Gy), specifically their production of reactive oxygen species (ROS) and their impact on cancer cells. ROS generated by AuNPs of varying sizes and coatings were quantified using fluorescence probes for hydroxyl radicals (HO·) and singlet oxygen (1O2). The radiosensitizing effects on MDA-MB-231 cancer cells were assessed via clonogenic assays. Our results show a clear dependence of ROS production on AuNP size. Interestingly, PEG-capped AuNPs did not significantly enhance HO· production but greatly increased 1O2 production, suggesting that multiple reactive species contribute to the radiosensitization process. Clonogenic assays confirmed that PEG-capped AuNPs produced stronger radiosensitizing effects than citrate-capped AuNPs, with smaller AuNPs providing more pronounced biological effects. This study underscores the importance of conducting both chemical and biological evaluations to fully understand the radiosensitization efficacy of AuNPs., This work was funded by Spanish MCIN/AEI/10.13039/501100011033 under NANORADIOTHER project (PID2021-127033OB-C22, PID2021-127033OB-C21) and CNS2023-144689 project, as well as by Comunidad de Madrid under ASAP-CM project (S2022/BMD-7434). S. España is supported by the Ministerio de Ciencia, Innovación y Universidades under Ayudas Ramón y Cajal RYC2018-024495-I. R. López-Méndez acknowledges MICINN for FPI grant PRE2020-96246. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). IMDEA Nanociencia acknowledges the “Severo Ochoa” program for Centres of Excellence in R&D (CEX2020-001039-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Exploring the radiosensitizing impact of gold nanoparticle formulations

  • Loscertales, E.
  • López-Méndez. R.
  • Mateo, J.
  • Fraile, L.M.
  • Udias, J.M.
  • Espinosa, A.
  • España, Samuel
7th Spanish Conference on Biomedical Applications of Nanomaterials, 19-20th september 2024, Madrid, Spain. 5 figuras, Cancer treatment with radiotherapy relies on high-energy radiation to destroy cancer cells by inducing DNA damage. The efficacy of this treatment can be enhanced using metallic nanoparticles, which act as radiosensitizers. These nanoparticles, particularly gold nanoparticles (AuNPs), can amplify the damage caused by radiation through increased production of reactive oxygen species (ROS) and localized energy deposition, potentially improving treatment outcomes. In this study, we investigated the production of various reactive oxygen species (ROS) using fluorescent sensors (figure 1, left) with a range of gold nanoparticles (AuNPs) including both commercial and synthesized AuNPs with different sizes and coatings. We also examined the radiosensitizing effect of these AuNPs in MDA-MB-231 breast cancer cells by conducting clonogenic assays (figure 1, right). All irradiations were performed using gamma radiation. The results reveal a distinct influence of both coating and size on ROS production. Specifically, certain coatings and sizes were more effective at enhancing ROS generation under gamma irradiation. When evaluating the radiosensitizing effects of AuNPs on breast cancer cells, the data showed a significant enhancement in radiosensitivity, but this enhancement did not correlate directly with the levels of ROS produced. These findings highlight the complexity of the interactions between nanoparticle characteristics and their biological effects under irradiation. While the coating and size of AuNPs play a critical role in ROS production, the mechanisms driving radiosensitization in cancer cells appear to be influenced by additional factors beyond ROS levels. Further studies are necessary to elucidate the underlying mechanisms., This work was funded by Comunidad de Madrid under ASAP project (S2022/BMD- 7434) and Ministerio de Ciencia e Innovaciónes under NANORADIOTHER Project (PID2021-127033OB-C21 & PID2021-127033OB-C22)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Enhancing Cancer Therapy Precision: Liposomal Nanocarriers for Controlled Drug Release under Ionizing Radiation

  • Loscertales, E.
  • Mateo, J.
  • España, Samuel
CRS 2024 Annual Meeting and Expo, 8-12 july 2024, Bologna, Italy 4 figuras., This work was funded by Comunidad de Madrid under ASAP project (S2022/BMD-7434) and Ministerio de Ciencia e Innovación under NANORADIOTHER Project (PID2021- 127033OB-C22)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optimizing liposomal drug release via γ-irradiation and iron-based radiosensitization

  • Loscertales, E.
  • España, Samuel
Chemotherapy remains a cornerstone of cancer treatment, yet its lack of tumor specificity often leads to systemic toxicity and limits the maximum tolerable dose. To address these limitations, drug-loaded nanocarriers responsive to ionizing radiation have emerged as a promising strategy to achieve localized drug release within irradiated tumor regions, thereby enhancing therapeutic efficacy while minimizing off-target effects. However, current radiation-responsive nanosystems often exhibit limited drug release at clinically relevant radiation doses. In our previous work, we evaluated liposomal formulations varying lipid composition, sensitizers, and particle size. While these systems demonstrated moderate immediate release upon irradiation followed by sustained passive leakage, they were incompatible with remote drug loading and failed to achieve rapid release. In the present study, we optimized the liposomal membrane composition through modulation of polyunsaturated and saturated phospholipids to enhance radiation sensitivity and colloidal stability. Furthermore, we introduced a radiosensitization mechanism based on the encapsulation of Fe³+ ions, which are reduced to Fe2+ upon γ-irradiation. This redox transition triggers a Fenton-like reaction that catalyzes the degradation of lipid hydroperoxides, leading to localized lipid peroxidation and membrane disruption. This dual strategy, membrane composition tuning and iron-mediated oxidative activation, resulted in significantly enhanced drug release upon exposure to low-dose radiation., This work was funded by the Spanish MCIN/AEI/10.13039/501100011033 through the NANORADIOTHER project (PID2021-127033OB-C22) and the NANOFIGHT project (PID2024-161273OB-C22); by the Comunidad de Madrid through the ASAP-CM project (S2022/BMD-7434); and by the TRANSCAN2024-2930-142_XPANTHER project, funded by the Instituto de Salud Carlos III and the Asociación Española Contra el Cáncer (AECC). It also received support within the framework of the LUNABRAIN-CM project, funded with €1.026 million by the Comunidad de Madrid through the R&D activities program in technologies, granted by Order 5696/2024. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN, and the Pro CNIC Foundation, and is recognized as a Severo Ochoa Center of Excellence (grant CEX2020-001041-S, funded by MICIN/AEI/10.13039/501100011033)., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

Impact of gold nanoparticle size and coating on radiosensitization and generation of reactive oxygen species in cancer therapy

  • Loscertales, E.
  • López-Méndez, R.
  • Mateo, J.
  • Fraile Prieto, Luis Mario
  • Udías Moinelo, José Manuel
  • Espinosa, A.
  • España, S.
Radiation therapy is a common cancer treatment but often damages surrounding healthy tissues, leading to unwanted side effects. Despite technological advancements aimed at improving targeting, minimizing exposure to normal cells remains a major challenge. High-Z nanoparticles, such as gold nanoparticles (AuNPs), are being explored as nano-radiosensitizers to enhance cancer treatment through physical, biological, and chemical mechanisms. This study focuses on evaluating the chemical and biological radiosensitizing effects of AuNPs exposed to ionizing radiation (0–50 Gy), specifically their production of reactive oxygen species (ROS) and their impact on cancer cells. ROS generated by AuNPs of varying sizes and coatings were quantified using fluorescence probes for hydroxyl radicals (HO·) and singlet oxygen (1O2). The radiosensitizing effects on MDA-MB-231 cancer cells were assessed via clonogenic assays. Our results show a clear dependence of ROS production on AuNP size. Interestingly, PEG-capped AuNPs did not significantly enhance HO· production but greatly increased 1O2 production, suggesting that multiple reactive species contribute to the radiosensitization process. Clonogenic assays confirmed that PEG-capped AuNPs produced stronger radiosensitizing effects than citrate-capped AuNPs, with smaller AuNPs providing more pronounced biological effects. This study underscores the importance of conducting both chemical and biological evaluations to fully understand the radiosensitization efficacy of AuNPs.